Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders: A Randomized, Double-blind, Placebo-controlled, Parallel-group, MRI Study

NCT05064319 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT05064319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05064319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders: A Randomized, Double-blind, Placebo-controlled, Parallel-group, MRI Study
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Completed
Start date
February 24, 2022
Completion date
July 31, 2026
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, bipolar i disorder, bipolar ii disorder, cannabis use, cannabis use disorder, mild, cannabis use disorder, moderate, cannabis use disorder, severe, schizoaffective disorder, bipolar type